DAM

DLD Asset Management Portfolio holdings

AUM $844M
This Quarter Return
+0.48%
1 Year Return
+2.69%
3 Year Return
+14.51%
5 Year Return
+47.59%
10 Year Return
AUM
$1.31B
AUM Growth
+$1.31B
Cap. Flow
-$291M
Cap. Flow %
-22.29%
Top 10 Hldgs %
77.3%
Holding
114
New
19
Increased
7
Reduced
9
Closed
30

Sector Composition

1 Healthcare 7.83%
2 Consumer Discretionary 2.46%
3 Industrials 2.21%
4 Technology 1.42%
5 Communication Services 0.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AVTR.PRA
26
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
$1.6M 0.08%
30,000
FOMX
27
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.6M 0.08%
525,000
BMRN icon
28
BioMarin Pharmaceuticals
BMRN
$11.2B
$1.54M 0.08%
22,800
-4,500
-16% -$303K
HHH icon
29
Howard Hughes
HHH
$4.53B
$1.43M 0.07%
+11,000
New +$1.43M
CVRS
30
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$939K 0.05%
+219,479
New +$939K
ENTX icon
31
Entera Bio
ENTX
$88.1M
$919K 0.05%
369,000
-442
-0.1% -$1.1K
ON icon
32
ON Semiconductor
ON
$20.3B
$863K 0.04%
+44,900
New +$863K
AMRN
33
Amarin Corp
AMRN
$311M
$758K 0.04%
50,000
+25,000
+100% +$379K
BKNG icon
34
Booking.com
BKNG
$181B
$300K 0.02%
153
-760
-83% -$1.49M
STI
35
DELISTED
SunTrust Banks, Inc.
STI
$244K 0.01%
3,543
-446,457
-99% -$30.7M
SPR icon
36
Spirit AeroSystems
SPR
$4.88B
$206K 0.01%
+2,500
New +$206K
PVLA
37
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$85K ﹤0.01%
+25,000
New +$85K
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$4.38B
0
AMGN icon
39
Amgen
AMGN
$155B
0
ATEX icon
40
Anterix
ATEX
$445M
-50,100
Closed -$2.36M
AVTR icon
41
Avantor
AVTR
$9.18B
0
BIIB icon
42
Biogen
BIIB
$19.4B
0
CLF icon
43
Cleveland-Cliffs
CLF
$5.32B
0
CNC icon
44
Centene
CNC
$14.3B
0
CXT icon
45
Crane NXT
CXT
$3.43B
-10,000
Closed -$834K
GOSS icon
46
Gossamer Bio
GOSS
$562M
0
LBTYA icon
47
Liberty Global Class A
LBTYA
$4B
-156,763
Closed -$4.23M
NVAX icon
48
Novavax
NVAX
$1.21B
0
SPY icon
49
SPDR S&P 500 ETF Trust
SPY
$658B
0
SRDX icon
50
Surmodics
SRDX
$487M
0